The 23 studies that the #FDA based its expanded #leucovorin label on.

The science supports it for a rare disorder with “autism-like’”symptoms.

The sole paper linking it to autism was retracted in January.

“Leucovorin prescriptions for children with autism increased by 71 percent after a White House briefing last September that promoted the drug as an #autism treatment.”

https://www.thetransmitter.org/spectrum/exclusive-the-23-studies-the-fda-based-its-expanded-leucovorin-label-on/